Skip to main content

. 1981 Jun;11(6):619–622. doi: 10.1111/j.1365-2125.1981.tb01180.x

Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients.

G Tedeschi, R Riva, A Baruzzi

PMCID: PMC1402199 PMID: 7272180

622

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs. 1980 Sep;20(3):161–178. doi: 10.2165/00003495-198020030-00001. [DOI] [PubMed] [Google Scholar]
Gastaut H., Low M. D. Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man. Epilepsia. 1979 Aug;20(4):437–446. doi: 10.1111/j.1528-1157.1979.tb04825.x. [DOI] [PubMed] [Google Scholar]
Vallner J. J., Needham T. E., Jun H. W., Brown W. J., Stewart J. T., Kotzan J. A., Honigberg I. L. Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol. 1978 Jul;18(7):319–324. doi: 10.1002/j.1552-4604.1978.tb01600.x. [DOI] [PubMed] [Google Scholar]
Volz M., Christ O., Kellner H. M., Kuch H., Fehlhaber H. W., Gantz D., Hajdu P., Cavagna F. Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol. 1979;7 (Suppl 1):41S–50S. doi: 10.1111/j.1365-2125.1979.tb04664.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES